Wan, B., Qin, L., Ma, W., & Wang, H. (2022). Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine. Infectious Agents & Cancer, 17(1), 1. https://doi.org/10.1186/s13027-022-00417-3
Chicago Style (17th ed.) CitationWan, Bing, Lu Qin, Weihong Ma, and He Wang. "Construction and Immune Effect of an HPV16/18/58 Trivalent Therapeutic Adenovirus Vector Vaccine." Infectious Agents & Cancer 17, no. 1 (2022): 1. https://doi.org/10.1186/s13027-022-00417-3.
MLA (9th ed.) CitationWan, Bing, et al. "Construction and Immune Effect of an HPV16/18/58 Trivalent Therapeutic Adenovirus Vector Vaccine." Infectious Agents & Cancer, vol. 17, no. 1, 2022, p. 1, https://doi.org/10.1186/s13027-022-00417-3.
Warning: These citations may not always be 100% accurate.